<DOC>
	<DOCNO>NCT00996580</DOCNO>
	<brief_summary>This open-label , single-treatment study . All subject receive 12 month oral contraceptive therapy DR-103 . Study participant receive physical gynecological exam , include Pap smear . During study , participant require complete diary .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety DR-103 Prevention Pregnancy</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Sexually active risk pregnancy Agreement use study OC therapy method birth control study history regular spontaneous menstrual cycle withdrawal bleed episode Others dictate FDAapproved protocol Any contraindication use oral contraceptive Pregnancy plan become pregnant next 14 month Smoker age â‰¥ 35 year Others dictate FDAapproved protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Contraception</keyword>
	<keyword>Oral contraceptive</keyword>
</DOC>